A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain

European Journal of Neuroscience

Volumn 36, Issue 6, 2012, Pages 2733-2742

  Long, Philip ^a   Samnakay, Parwez ^a   Jenner, Peter ^a   Rose, Sarah ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chaperone protein; Growth factor; Osteopontin; Parkinson's disease; Rat brain

Indexed keywords

MEMBRANE PROTEIN; OSTEOPONTIN; PROTEASOME; PROTEASOME BETA1; PROTEIN BAG6; PROTEIN DNAJ; PROTEIN DNAJB1; PROTEIN EF1A; PROTEIN MAP1A; PROTEIN MAP1B; PROTEIN RNF138; PROTEIN SGTA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MICROTUBULE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; RAT; SITE DIRECTED MUTAGENESIS; SUBSTANTIA NIGRA; TWO HYBRID SYSTEM;

ANIMALS; APOPTOSIS; BRAIN; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; OSTEOPONTIN; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOLYSIS; RATS; RATS, WISTAR; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84866348683     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2012.08189.x     Document Type: Article

References (84)

1. Abeliovich, A. & Flint, B.M. (2006) Parkinsonism genes: culprits and clues. J. Neurochem., 99, 1062-1072.
2. Agnihotri, R., Crawford, H.C., Haro, H., Matrisian, L.M., Havrda, M.C. & Liaw, L. (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J. Biol. Chem., 276, 28261-28267.
3. Alim, M.A., Hossain, M.S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S. & Ueda, K. (2002) Tubulin seeds alpha-synuclein fibril formation. J. Biol. Chem., 277, 2112-2117.
4. Alvarez-Erviti, L., Rodriguez-Oroz, M.C., Cooper, J.M., Caballero, C., Ferrer, I., Obeso, J.A. & Schapira, A.H. (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol., 67, 1464-1472.
5. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.T., Michel, P.P., Marquez, J., Mouatt-Prigent, A., Ruberg, M., Hirsch, E.C. & Agid, Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol., 12, 25-31.
6. Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Ueda, K., Ikeda, K. & Kawai, M. (1999) Cellular co-localization of phosphorylated tau- and NACP/alpha synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Brain Res., 843, 53-61.
7. Asou, Y., Rittling, S.R., Yoshitake, H., Tsuji, K., Shinomiya, K., Nifuji, A., Denhardt, D.T. & Noda, M. (2001) Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology, 142, 1325-1332.
8. Bandopadhyay, R. & de Belleroche, J. (2009) Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends Mol. Med., 16, 27-36.
9. Beninati, S., Senger, D.R., Cordella-Miele, E., Mukherjee, A.B., Chackalaparampil, I., Shanmugam, V., Singh, K. & Mukherjee, B.B. (1994) Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J. Biochem., 115, 675-682.
10. Biskup, S., Moore, D.J., Celsi, F., Higashi, S., West, A.B., Andrabi, S.A., Kurkinen, K., Yu, S.W., Savitt, J.M., Waldvogel, H.J., Faull, R.L., Emson, P.C., Torp, R., Ottersen, O.P., Dawson, T.M. & Dawson, V.L. (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol., 60, 557-569.
11. Breeden, L. & Nasmyth, K. (1985) Regulation of the yeast HO gene. Cold Spring Harb. Symp. Quant. Biol., 50, 643-650.
12. Bukhatwa, S., Zeng, B.Y., Rose, S. & Jenner, P. (2010) A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Brain Res., 1326, 174-183.
13. Christensen, B., Kazanecki, C.C., Petersen, T.E., Rittling, S.R., Denhardt, D.T. & Sorensen, E.S. (2007) Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem., 282, 19463-19472.
14. D'Andrea, L.D. & Regan, L. (2003) TPR proteins: the versatile helix. Trends Biochem. Sci., 28, 655-662.
15. DeMartino, G.N. & Slaughter, C.A. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem., 274, 22123-22126.
16. Desmots, F., Russell, H.R., Michel, D. & McKinnon, P.J. (2007) Scythe regulates apoptosis-inducing factor stability during endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem., 283, 3264-3271.
17. Deuel, T.F., Zhang, N., Yeh, H.J., Silos-Santiago, I. & Wang, Z.Y. (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch. Biochem. Biophys., 397, 162-171.
18. Ding, J., Liu, J.J., Kowal, A.S., Nardine, T., Bhattacharya, P., Lee, A. & Yang, Y. (2002) Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J. Cell. Biol., 158, 427-433.
19. Fink, J.K., Jones, S.M., Esposito, C. & Wilkowski, J. (1996) Human microtubule associated protein 1a (MAP1A) gene: genomic organization, cDNA sequence, and developmental- and tissue-specific expression. Genomics, 35, 577-585.
20. Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D. & Link, C.D. (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. USA, 99, 9439-9444.
21. Freeman, B.C., Myers, M.P., Schumacher, R. & Morimoto, R.I. (1995) Identification of a regulatory motif in Hsp70 that affects ATPase activity, substrate binding and interaction with HDJ-1. EMBO J., 14, 2281-2292.
22. Gao, C., Guo, H., Wei, J. & Kuo, P.C. (2003) Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun., 309, 120-125.
23. Gietz, R.D., Schiestl, R.H., Willems, A.R. & Woods, R.A. (1995) Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast, 11, 355-360.
24. Gillardon, F. (2009a) Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability-a point of convergence in parkinsonian neurodegeneration. J. Neurochem., 110, 1514-1522.
25. Gillardon, F. (2009b) Interaction of elongation factor 1-alpha with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro. Neuroscience, 163, 533-539.
26. Gloeckner, C.J., Kinkl, N., Schumacher, A., Braun, R.J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H. & Ueffing, M. (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet., 15, 223-232.
27. Gotoh, T., Terada, K. & Mori, M. (2001) hsp70-DnaJ chaperone pairs prevent nitric oxide-mediated apoptosis in RAW 264.7 macrophages. Cell Death. Differ., 8, 357-366.
28. Gotoh, T., Terada, K., Oyadomari, S. & Mori, M. (2004) hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death. Differ., 11, 390-402.
29. Hamza, T.H., Zabetian, C.P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D.M., Doheny, K.F., Paschall, J., Pugh, E., Kusel, V.I., Collura, R., Roberts, J., Griffith, A., Samii, A., Scott, W.K., Nutt, J., Factor, S.A. & Payami, H. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet., 42, 781-785.
30. Harrison, B., Kraus, M., Burch, L., Stevens, C., Craig, A., Gordon-Weeks, P. & Hupp, T.R. (2008) DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J. Biol. Chem., 283, 9999-10014.
31. Hartmann, A., Hunot, S., Michel, P.P., Muriel, M.P., Vyas, S., Faucheux, B.A., Mouatt Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., Evan, G.I., Agid, Y. & Hirsch, E.C. (2000) Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA, 97, 2875-2880.
32. He, C. & Klionsky, D.J. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet., 2009, 67-93.
33. Hida, H., Jung, C.G., Wu, C.Z., Kim, H.J., Kodama, Y., Masuda, T. & Nishino, H. (2003) Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur. J. Neurosci, 17, 2127-2134.
34. Hida, H., Masuda, T., Sato, T., Kim, T.S., Misumi, S. & Nishino, H. (2007) Pleiotrophin promotes functional recovery after neural transplantation in rats. Neuroreport, 18, 179-183.
35. Hirsch, E.C., Hunot, S., Faucheux, B., Agid, Y., Mizuno, Y., Mochizuki, H., Tatton, W.G., Tatton, N. & Olanow, W.C. (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov. Disord., 14, 383-385.
36. Iczkiewicz, J., Rose, S. & Jenner, P. (2004) Osteopontin (Eta-1) is present in the rat basal ganglia. Brain Res. Mol. Brain Res., 132, 64-72.
37. Iczkiewicz, J., Rose, S. & Jenner, P. (2005) Increased osteopontin expression followin intranigral lipopolysaccharide injection in the rat. Eur. J. Neurosci, 21, 1911-1920.
38. Iczkiewicz, J., Jackson, M.J., Smith, L.A., Rose, S. & Jenner, P. (2006) Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease. Brain Res., 1118, 239-250.
39. Iczkiewicz, J., Broom, L., Cooper, J.D., Wong, A.M., Rose, S. & Jenner, P. (2010) The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra. J. Neurochem., 114, 1792-1804.
40. Inbal, B., Bialik, S., Sabanay, I., Shani, G. & Kimchi, A. (2002) DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol., 157, 455-468.
41. Jensen, P.H., Islam, K., Kenney, J., Nielsen, M.S., Power, J. & Gai, W.P. (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J. Biol. Chem., 275, 21500-21507.
42. Jiang, Q., Yan, Z. & Feng, J. (2006) Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons. J. Biol. Chem., 281, 29391-29400.
43. Kalchman, M.A., Graham, R.K., Xia, G., Koide, H.B., Hodgson, J.G., Graham, K.C., Goldberg, Y.P., Gietz, R.D., Pickart, C.M. & Hayden, M.R. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem., 271, 19385-19394.
44. Keykhosravani, M., Doherty-Kirby, A., Zhang, C., Brewer, D., Goldberg, H.A., Hunter, G.K. & Lajoie, G. (2005) Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry, 44, 6990-7003.
45. Kingsbury, A.E., Mardsen, C.D. & Foster, O.J. (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?Mov. Disord., 13, 877-884.
46. Kinnunen, A., Niemi, M., Kinnunen, T., Kaksonen, M., Nolo, R. & Rauvala, H. (1999) Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain. Eur. J. Neurosci, 11, 491-502.
47. Lampe, M.A., Patarca, R., Iregui, M.V. & Cantor, H. (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol., 147, 2902-2906.
48. Lee, M.Y., Shin, S.L., Choi, Y.S., Kim, E.J., Cha, J.H., Chun, M.H., Lee, S.B. & Kim, S.Y. (1999) Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats. Neurosci. Lett., 271, 81-84.
49. L'episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Cossetti, C., D'Adamo, P., Zardini, E., Andreoni, L., Ihekwaba, A.E., Serra, P.A., Franciotta, D., Martino, G., Pluchino, S. & Marchetti, B. (2011) Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis., 41, 508-527.
50. Li, L., Wang, X., Fei, X., Xia, L., Qin, Z. & Liang, Z. (2011) Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci. Lett., 489, 62-67.
51. Liaw, L., Birk, D.E., Ballas, C.B., Whitsitt, J.S., Davidson, J.M. & Hogan, B.L. (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest, 101, 1468-1478.
52. Maetzler, W., Berg, D., Schalamberidze, N., Melms, A., Schott, K., Mueller, J.C., Liaw, L., Gasser, T. & Nitsch, C. (2007) Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol. Dis., 25, 473-482.
53. Marchionini, D.M., Lehrmann, E., Chu, Y., He, B., Sortwell, C.E., Becker, K.G., Freed, W.J., Kordower, J.H. & Collier, T.J. (2007) Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res., 1147, 77-88.
54. Marty, C., Browning, D.D. & Ye, R.D. (2003) Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras. Mol.Cell Biol., 23, 3847-3858.
55. McDonough, H. & Patterson, C. (2003) CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones, 8, 303-308.
56. McNaught, K.S. & Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett., 297, 191-194.
57. McNaught, K.S., Olanow, C.W., Halliwell, B., Isacson, O. & Jenner, P. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci, 2, 589-594.
58. McNaught, K.S., Belizaire, R., Jenner, P., Olanow, C.W. & Isacson, O. (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett., 326, 155-158.
59. McNaught, K.S., Perl, D.P., Brownell, A.L. & Olanow, C.W. (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol., 56, 149-162.
60. Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P. & Nagatsu, T. (1996) bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci. Lett., 215, 137-139.
61. Nacharaju, P., Lewis, J., Easson, C., Yen, S., Hackett, J., Hutton, M. & Yen, S.H. (2001) Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett., 447, 195-199.
62. Nau, G.J., Guilfoile, P., Chupp, G.L., Berman, J.S., Kim, S.J., Kornfeld, H. & Young, R.A. (1997) A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. USA, 94, 6414-6419.
63. Nemir, M., DeVouge, M.W. & Mukherjee, B.B. (1989) Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J. Biol. Chem., 264, 18202-18208.
64. Noti, J.D. (2000) Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha. Int. J. Oncol., 17, 1237-1243.
65. Piltonen, M., Bespalov, M.M., Ervasti, D., Matilainen, T., Sidorova, Y.A., Rauvala, H., Saarma, M. & Mannisto, P.T. (2009) Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. Exp. Neurol., 219, 499-506.
66. Rauvala, H. & Peng, H.B. (1997) HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and plasticity of neuron-target contacts. Prog. Neurobiol., 52, 127-144.
67. Rollo, E.E., Laskin, D.L. & Denhardt, D.T. (1996) Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J. Leukoc. Biol., 60, 397-404.
68. Sasaki, T., Gan, E.C., Wakeham, A., Kornbluth, S., Mak, T.W. & Okada, H. (2007) HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediate acetylation of p53. Genes Dev., 21, 848-861.
69. Schoenfeld, T.A., McKerracher, L., Obar, R. & Vallee, R.B. (1989) MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS. J. Neurosci., 9, 1712-1730.
70. Senger, D.R., Perruzzi, C.A., Papadopoulos-Sergiou, A. & Van de, W.L. (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin cleavage in close proximity to the GRGDS cell-binding domain. Mol. Biol. Cell, 5, 565-574.
71. Shanmugam, V., Chackalaparampil, I., Kundu, G.C., Mukherjee, A.B. & Mukherjee, B.B. (1997) Altered sialylation of osteopontin prevents its receptor mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry, 36, 5729-5738.
72. Shin, S.L., Cha, J.H., Chun, M.H., Chung, J.W. & Lee, M.Y. (1999) Expression of osteopontin mRNA in the adult rat brain. Neurosci. Lett., 273, 73-76.
73. Smith, D.B. & Johnson, K.S. (1988) Single-step purification of polypeptides expressed in Escherischia coli as fusions with glutathione S-transferase. Gene, 67, 31-40.
74. Smith, J.H. & Denhardt, D.T. (1987) Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J. Cell Biochem., 34, 13-22.
75. Song, S., Kim, S.Y., Hong, Y.M., Jo, D.G., Lee, J.Y., Shim, S.M., Chung, C.W., Seo, S.J., Yoo, Y.J., Koh, J.Y., Lee, M.C., Yates, A.J., Ichijo, H. & Jung, Y.K. (2003) Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity. Mol. Cell, 12, 553-563.
76. Sorensen, E.S., Hojrup, P. & Petersen, T.E. (1995) Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O glycosylation sites. Protein Sci., 4, 2040-2049.
77. Tanji, K., Mori, F., Kakita, A., Takahashi, H. & Wakabayashi, K. (2011) Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol. Dis., 43, 690-697.
78. Tatton, N.A. (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol., 166, 29-43.
79. Wang, H., Shen, H., Wang, Y., Li, Z., Yin, H., Zong, H., Jiang, J. & Gu, J. (2005) Overexpression of small glutamine-rich TPR-containing protein promotes apoptosis in 7721 cells. FEBS Lett., 579, 1279-1284.
80. Weber, G.F., Adler, G. & Ashkar, S. 1999. Osteopontin in oxidative stress responses. In Ruffolo, R.R. Jr, Feuerstein, G.Z., Hunter, A.J., Poste, G. & Metcalf, B.W. (Eds), Inflammatory Cells and Mediators in CNS Diseases. Harwood Academic Publishers, Amsterdam, pp. 97-112.
81. Yamada, M., Ohnishi, J., Ohkawara, B., Iemura, S., Satoh, K., Hyodo-Miura, J., Kawachi, K., Natsume, T. & Shibuya, H. (2006) NARF, an nemo-like kinase (NLK) associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J. Biol. Chem., 281, 20749-20760.
82. Yang, F., Jiang, Q., Zhao, J., Ren, Y., Sutton, M.D. & Feng, J. (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J. Biol. Chem., 280, 17154-17162.
83. Yin, H., Wang, H., Zong, H., Chen, X., Wang, Y., Yun, X., Wu, Y., Wang, J. & Gu, J. (2006) SGT, a Hsp90beta binding partner, is accumulated in the nucleus during cell apoptosis. Biochem. Biophys. Res. Commun., 343, 1153-1158.
84. Zhang, J., Guo, H., Mi, Z., Gao, C., Bhattacharya, S., Li, J. & Kuo, P.C. (2008) EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Exp.Cell Res., 315, 304-312.